Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A Positive Control for Detection of Functional CD4 T Cells in PBMC: The CPI Pool.

Schiller A, Zhang T, Li R, Duechting A, Sundararaman S, Przybyla A, Kuerten S, Lehmann PV.

Cells. 2017 Dec 7;6(4). pii: E47. doi: 10.3390/cells6040047.

2.

How frequently are predicted peptides actually recognized by CD8 cells?

Moldovan I, Targoni O, Zhang W, Sundararaman S, Lehmann PV.

Cancer Immunol Immunother. 2016 Jul;65(7):847-55. doi: 10.1007/s00262-016-1840-7. Epub 2016 Apr 23. Review.

3.

Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity.

Wunsch M, Zhang W, Hanson J, Caspell R, Karulin AY, Recks MS, Kuerten S, Sundararaman S, Lehmann PV.

Viruses. 2015 Aug 6;7(8):4414-37. doi: 10.3390/v7082828.

4.

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells.

Hanson J, Sundararaman S, Caspell R, Karacsony E, Karulin AY, Lehmann PV.

Cells. 2015 Jan 29;4(1):71-83. doi: 10.3390/cells4010071.

5.

ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting.

Karulin AY, Karacsony K, Zhang W, Targoni OS, Moldovan I, Dittrich M, Sundararaman S, Lehmann PV.

Cells. 2015 Jan 20;4(1):56-70. doi: 10.3390/cells4010056.

6.

Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay.

Wunsch M, Caspell R, Kuerten S, Lehmann PV, Sundararaman S.

Cells. 2015 Jan 9;4(1):40-55. doi: 10.3390/cells4010040.

7.

High Reproducibility of ELISPOT Counts from Nine Different Laboratories.

Sundararaman S, Karulin AY, Ansari T, BenHamouda N, Gottwein J, Laxmanan S, Levine SM, Loffredo JT, McArdle S, Neudoerfl C, Roen D, Silina K, Welch M, Lehmann PV.

Cells. 2015 Jan 9;4(1):21-39. doi: 10.3390/cells4010021.

Supplemental Content

Loading ...
Support Center